About Company
signablok is a biopharmaceutical company, that provides signaling chain homooligomerization platform basics, macrophage modulation, macrophage imaging, pipeline, therapeutic programs for autoimmune diseases, atherosclerosis, retinopathy, sepsis, ards, and covid, science, and management develops novel targeted therapeutics and delivery nanosystems.
